{
  "pmcid": "2865602",
  "sha256": "245d9119ad7dbc2324eb1da7c393369a19cbc752e029562d81f4b5918b6bc122",
  "timestamp_utc": "2025-11-09T15:50:15.286545+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.238936823104698,
    "reading_ease": 39.153423285198585,
    "word_count": 277
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "We randomly divided 94 patients into two treatment groups."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "percutaneous repetitive sclerotherapy using polidocanol (Group 1) with those with intralesional excision (extended curettage with a high-speed burr) and bone grafting (Group 2)"
      },
      "Objective": {
        "score": 1,
        "evidence": "We therefore compared the healing rates and functional scores in patients having percutaneous repetitive sclerotherapy using polidocanol (Group 1) with those with intralesional excision (extended curettage with a high-speed burr) and bone grafting (Group 2) for treatment of aneurysmal bone cyst."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "We assessed healing rates (primary outcome measure), pain relief, time to healing and recurrence, hospital stay, and the Enneking functional score."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "We randomly divided 94 patients into two treatment groups."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "We randomly divided 94 patients into two treatment groups."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Forty-five patients from Group 1 and 46 from Group 2 were available for study."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "At last followup, 93.3% in Group 1 and 84.8% in Group 2 had achieved healing."
      },
      "Harms": {
        "score": 1,
        "evidence": "Complications in Group 1 were minor and resolved. In Group 2, three patients had deep infections and five had superficial infections, and two had growth disturbances."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}